网 站
反 馈
网 站
指 南
Order NO. D263659
兔抗CYSLTR2多克隆抗体
英文名 Anti-CYSLTR2 rabbit polyclonal antibody
别名 cysteinyl leukotriene receptor 2 HG57; CYSLT2; GPCR21; HPN321; CYSLT2R; KPG_011; hGPCR21; PSEC0146
相关类别 一抗 储存 冷冻(-20℃)
宿主 Rabbit 反应种属 Human, Mouse
标记物 Unconjugate 克隆类型 rabbit polyclonal
抗原 CYSLTR2    
   
编 号 包装 库存 目录价(¥) 您的价格(¥) 数 量
D263659-0025 25 ul 现货
加入购物车
D263659-0100 100 ul 现货
加入购物车
D263659-0200 200 ul 现货
加入购物车

技术规格

Background: The cysteinyl leukotrienes LTC4, LTD4, and LTE4 are important mediators of human bronchial asthma. Pharmacologic studies have determined that cysteinyl leukotrienes activate at least 2 receptors, the protein encoded by this gene and CYSLTR1. This encoded receptor is a member of the superfamily of G protein-coupled receptors. It seems to play a major role in endocrine and cardiovascular systems.
Applications: ELISA, WB, IHC
Name of antibody: CYSLTR2
Immunogen: Synthetic peptide of human CYSLTR2
Full name: cysteinyl leukotriene receptor 2
Synonyms: HG57; CYSLT2; GPCR21; HPN321; CYSLT2R; KPG_011; hGPCR21; PSEC0146
SwissProt: Q9NS75
ELISA Recommended dilution: 5000-10000
IHC positive control: Human gastric cancer and Human liver cancer
IHC Recommend dilution: 20-100
WB Predicted band size: 40 kDa
WB Positive control: Mouse adrenal gland tissue lysate
WB Recommended dilution: 200-1000
相关文档
Sample Application

  • The image on the left is immunohistochemistry of paraffin-embedded Human gastric cancer tissue using D263659(CYSLTR2 Antibody) at dilution 1/20, on the right is treated with synthetic peptide. (Original magnification: ×200)


  • The image on the left is immunohistochemistry of paraffin-embedded Human liver cancer tissue using D263659(CYSLTR2 Antibody) at dilution 1/20, on the right is treated with synthetic peptide. (Original magnification: ×200)


  • Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane: Mouse adrenal gland tissue lysate, Primary antibody: D263659(CYSLTR2 Antibody) at dilution 1/300, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 40 seconds
    我的购物车(0) 结算